The primary obstacle in cell engineering continues to be the generation of single-cell clones, significantly impacting the pace and effectiveness of research.
Download this poster from Kite Pharma, a Gilead Company, which offers a thorough analysis of four distinct platforms based on these factors:
Complete the form to get the poster.
Learn about the most efficient way to generate an abundance of monoclonal colonies from single cells.